We cloned a cDNA encoding a novel lysyl oxidaserelated protein, named LOXC, by suppression subtractive hybridization between differentiated and calcified ATDC5 cells, a clonal mouse chondrogenic EC cell line. The deduced amino acid sequence of mouse LOXC consists of 757 amino acids and shows 50% identity with that of mouse lysyl oxidase. Northern blot analysis showed a distinct hybridization band of 5.4 kilobases, and Western blot analysis showed an immunoreactive band at 82 kilodaltons. Expression of LOXC mRNA was detected in osteoblastic MC3T3-E1 cells and embryonic fibroblast C3H10T1/2 cells, whereas none of NIH3T3 fibroblasts and myoblastic C2C12 cells expressed LOXC mRNA in vitro. Moreover, the LOXC mRNA and protein levels dramatically increased throughout a process of chondrogenic differentiation in ATDC5 cells. In vivo, LOXC gene expression was localized in hypertrophic and calcified chondrocytes of growth plates in adult mice. The conditioned media of COS-7 cells transfected with the fulllength LOXC cDNA showed the lysyl oxidase activity in both type I and type II collagens derived from chick embryos, and these activities of LOXC were inhibited by -aminopropionitrile, a specific inhibitor of lysyl oxidase. Our data indicate that LOXC is expressed in cartilage in vivo and modulates the formation of a collagenous extracellular matrix.Endochondral bone formation is a multistep programmed event in skeletal development. Undifferentiated mesenchymal chondroprogenitor cells differentiate into chondrocytes through a cellular condensation process. Such chondrocytes surround themselves with an abundant layer of extracellular matrix, including type II, IX, and XI collagens, that is characteristic of cartilage (1, 2). These cells go through sequential processes of proliferation and maturation and then change their genetic program to be converted into hypertrophic and calcified chondrocytes, expressing type X collagen. These events are under the regulatory control of a variety of growth and differentiation modulating factors, including bone morphogenetic proteins (3, 4), fibroblast growth factors (5, 6), parathyroid hormone-related peptide (7-9), and Indian hedgehog (10). It is also clear that the components of extracellular matrix in cartilage play important roles in modulating and maintaining the phenotype of chondrocytes. During a process of hypertrophic conversion and calcification of chondrocytes, mineralization of extracellular matrix occurs before these chondrocytes are replaced by bone tissues. However, the molecular mechanisms underlying these sequential events remain largely unknown.We previously reported that the clonal mouse cell line, ATDC5, enables the monitoring of the multistep chondrogenic differentiation in a single culture (11)(12)(13)(14). When cultured in the presence of insulin, ATDC5 cells form cartilaginous nodules through cellular condensation. When the formation of cartilage nodules is completed, the cells are then converted to type X collagen-expressing hypertrophic chondrocytes, following...